Register for our free email digests:
DiaSorin SpA
http://www.diasorin.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From DiaSorin SpA
Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.
Sonica Health Develops Wearable For Early Warning Of COVID-19
The US government is helping Sonica develop ADAM, a patch monitor that tracks the user's breathing patterns and other physiologic signals to detect SARS-CoV-2 infections.
FDA Grants EUA For Roche’s Coronavirus Antibody Test
The company says the serology test has a specificity of 99.8% and sensitivity of 100%
Controversial Italian COVID-19 IVDs Tender Must Not Be A Blueprint For The Future, Says Industry
Italy must ensure that ongoing efforts to tackle the coronavirus crisis do not rely on single suppliers, the country's medtech industry body said after DiaSorin looked likely to be the sole winner of a major COVID-19 diagnostics tender.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Other Names / Subsidiaries
-
- Biotrin International
- DiaSorin Molecuular
- Focus Diagnostics